3rd Quarter - Termination

SQUIRE PATTON BOGGS for BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.

Firm
Client
Income
$10,000
Expenses
—
Terminated
Sep 30, 2010

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reimbursement and regulation of pharmaceutical and biological products in P.L. 111-148 ( The Patient Protection and Affordable Care Act ) and P.L. 111-152 ( The Health Care and Education Reconciliation Act ).

LobbyistCovered position, as disclosed
JENNIFER BELL LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

S. 515, H.R. 1260, Patent Reform Act of 2009, S. 525/1252, H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009, S. 729, H.R. 1427, Promoting Innovation and Access to Live-Savings Medicine Act of 2009

LobbyistCovered position, as disclosed
JENNIFER BELL LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 729 (111th), H.R. 1260 (111th), H.R. 1298 (111th), S. 525 (111th), S. 515 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.